Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1999
12/23/1999CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2331197A1 Hiv virus mimotopes
12/23/1999CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999CA2331151A1 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999CA2330824A1 Hla binding peptides and their uses
12/23/1999CA2330544A1 A novel gene and method of treating a gram negative bacterial infection
12/23/1999CA2330209A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999CA2328504A1 Immunotherapeutic composition and method for the treatment of prostate cancer
12/22/1999EP0965640A1 GP75 as a tumor vaccine for melanoma
12/22/1999EP0965639A1 Attenuated pestiviruses
12/22/1999EP0965595A1 Protein complex
12/22/1999EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999EP0965345A2 Use of acemannan
12/22/1999EP0965336A1 Microencapsulated DNA for gene therapy
12/22/1999EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999EP0964924A1 Iron regulated promoter and uses thereof
12/22/1999EP0964921A1 Novel streptococcal ers
12/22/1999EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999EP0964868A1 Isolated peptides derived from mage-2
12/22/1999EP0964700A1 Pharmaceutical preparation and method for treatment and prevention of fibromyalgia and chronic fatigue
12/22/1999EP0964699A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF
12/22/1999EP0964698A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
12/22/1999EP0964697A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
12/22/1999EP0964696A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
12/22/1999EP0964694A1 Mucin-mediated immunomodulation
12/22/1999EP0964689A1 Recombinant vaccine for diseases caused by encapsulated organisms
12/22/1999EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999CN1239512A Replication-competent recombinant sabin type 1 strain of pollovirus
12/22/1999CN1239479A Mage-1- encoding cDNA, tumor rejection antigen precursor mage-10, antibodies specific to molecule, and uses thereof
12/22/1999CN1239431A Immunogenic TLP compsn.
12/22/1999CN1047666C Immunity detection method of releasing antigen from antibodies
12/21/1999US6005099 For immunomodulators, antitumor agents, and components of vaccines with reduced endotoxicity
12/21/1999US6005091 Nucleic acids encoding immunoglobulin domains
12/21/1999US6005090 Treatment and prevention of helicobacter infection
12/21/1999US6005074 Cloning of human GPR14 receptor
12/21/1999US6004815 Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
12/21/1999US6004807 Generating cancer-specific or virus-specific cd8+ cytotoxic t cells by culturing cd8+ t cells from patient with cancer or viral antigen-pulsed dendritic cells to sensitize and cause proliferation of the t cells; anticancer agents; viricides
12/21/1999US6004802 Oral administration of pneumococcal antigens
12/21/1999US6004799 Recombinant live feline immunodeficiency virus and proviral DNA vaccines
12/21/1999US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis
12/21/1999US6004763 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
12/21/1999US6004564 Method for increasing the yield of antibodies in the techniques of immunology
12/21/1999US6004563 Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
12/21/1999US6004562 Outer membrane protein B1 of Moraxella catarrhalis
12/21/1999US6004561 High level expression of polypeptide that contains modified preS1 region of hepatitis B virus large antigen
12/21/1999US6004557 Variants of human papillomavirus antigens
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/21/1999US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999US6004535 Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies
12/21/1999US6004354 IceA gene and related methods
12/21/1999CA2065287C New hcv isolates
12/21/1999CA1340858C Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
12/19/1999CA2242316A1 Dna encoding a plasminogen activating protein
12/16/1999WO1999064633A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999WO1999064615A1 Formulations for electroporation
12/16/1999WO1999064610A1 ZmpB, A NEW DETERMINANT OF VIRULENCE FOR STREPTOCOCCUS PNEUMONIAE, VACCINE DERIVED THEREFROM AND USES THEREOF
12/16/1999WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999WO1999064604A2 Attenuated pestiviruses
12/16/1999WO1999064603A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
12/16/1999WO1999064602A2 Moraxella catarrhalis polynucleotides and polypeptides
12/16/1999WO1999064597A1 β2 MICROGLOBULIN FUSION PROTEINS AND HIGH AFFINITY VARIANTS
12/16/1999WO1999064596A2 Proteins regulating gene expression
12/16/1999WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
12/16/1999WO1999064591A1 Antibody against lar phosphatase subunit
12/16/1999WO1999064588A1 TGFβ RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES
12/16/1999WO1999064586A2 Phagocytic assay method
12/16/1999WO1999064571A1 Interferon inducing genetically engineered attenuated viruses
12/16/1999WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
12/16/1999WO1999064462A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
12/16/1999WO1999064461A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
12/16/1999WO1999064460A1 Divalent antibody fragments
12/16/1999WO1999064448A2 Moraxella catarrhalis pilq proteins
12/16/1999WO1999064435A1 The human kidney specific gene kk86
12/16/1999WO1999064074A1 Methods and compositions for delivering proteins to macrophage cells and cells of macrophage derived lineage
12/16/1999WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999WO1999064067A2 Vaccine
12/16/1999WO1999064064A1 Acrosomal sperm protein and uses thereof
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063975A2 A method for stimulating the immune system
12/16/1999WO1999063945A2 Vaccination strategy to prevent and treat cancers
12/16/1999WO1999063941A2 Novel hepatitis c virus peptides and uses thereof
1 ... 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 ... 1823